Can you provide the last earnings date for ONCONOVA THERAPEUTICS INC?
ONCONOVA THERAPEUTICS INC (ONTX) last reported earnings on 3/7/2024.
ONCONOVA THERAPEUTICS INC (ONTX) Earnings History & Surprises
NASDAQ:ONTX • US68232V8019
Current stock price
0.9953 USD
0 (-0.47%)
At close:
0.9012 USD
-0.09 (-9.45%)
After Hours:
ONTX Earnings overview
Past quarterly earnings results for ONCONOVA THERAPEUTICS INC (ONTX), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 13, 2024
- Period
- Q4 / 2023
- EPS Estimate
- -$0.26
- Revenue Estimate
- 66.637K
Last Reported
Most Recent- Release Date
- Mar 7, 2024
- Period
- Q3 / 2023
- EPS Reported
- -$0.23
- EPS Surprise
- 22.24%
- Revenue Surprise
- -19.30%
Beat Rate
Last 8 Quarters 56%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2023 | -0.23 | -0.30 | 22.24% | 11.54% | 57K | 70.635K | -19.30% | -5.00% |
| Q2 2023 | -0.20 | -0.32 | 37.25% | -5.26% | 60K | 70.635K | -15.06% | - |
| Q1 2023 | -0.28 | -0.30 | 7.73% | -40.00% | 60K | 90.78K | -33.91% | - |
| Q4 2022 | -0.26 | -0.29 | 8.96% | -73.33% | 60K | 59.16K | 1.42% | - |
| Q3 2022 | -0.26 | -0.22 | -19.95% | -18.18% | 60K | 58.905K | 1.86% | - |
| Q2 2022 | -0.19 | -0.20 | 5.68% | 29.63% | 60K | 58.395K | 2.75% | - |
| Q1 2022 | -0.20 | -0.19 | -3.20% | 33.33% | 60K | 87.037K | -31.06% | - |
| Q4 2021 | -0.15 | -0.28 | 45.53% | 66.67% | 60K | 60.69K | -1.14% | - |
| Q3 2021 | -0.22 | -0.33 | 33.97% | 51.11% | 60K | 54.397K | 10.30% | -14.29% |
| Q2 2021 | -0.27 | -0.29 | 7.12% | 55.00% | 60K | 20.4K | 194.12% | - |
| Q1 2021 | -0.30 | -0.46 | 34.64% | 33.33% | 60K | 61.2K | -1.96% | 20.00% |
| Q4 2020 | -0.45 | -0.54 | 15.97% | - | 60K | 40.8K | 47.06% | - |
| Q3 2020 | -0.45 | -0.51 | 11.76% | - | 70K | 1.422M | -95.08% | - |
| Q2 2020 | -0.60 | -0.46 | -30.72% | - | 60K | 176.46K | -66.00% | - |
| Q1 2020 | -0.45 | -0.84 | 46.52% | - | 50K | 157.08K | -68.17% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
4
Average EPS beat (4)
19.05%
Max EPS beat (4)
37.25%
Min EPS beat (4)
7.73%
Revenue beat statistics
Revenue beat (4)
1
Average Revenue beat (4)
-16.71%
Max Revenue beat (4)
1.42%
Min Revenue beat (4)
-33.91%
Analysis
In the last 4 quarters, ONTX has consistently beaten EPS estimates in all releases
ONTX has beaten revenue estimates in 1 out of the last 4 releases
In the last 4 quarters, ONTX has beaten the EPS estimates by 19.0% on average.
In the last 4 quarters, ONTX reported -16.7% below the revenue estimates on average.
Related analysis
ONCONOVA THERAPEUTICS INC / ONTX Earnings FAQ
Did ONTX stock beat earnings estimates in the most recent quarter?
ONCONOVA THERAPEUTICS INC (ONTX) beat EPS estimates and missed revenue estimates in the most recent quarter.
How often does ONCONOVA THERAPEUTICS INC (ONTX) beat earnings estimates?
In the last 4 quarters, ONCONOVA THERAPEUTICS INC (ONTX) has beaten EPS estimates in 4 out of 4 releases.